The global behavioral health market, currently valued at an estimated USD127 billion in 2024, is poised for substantial expansion, with projections indicating it will generate revenues of USD175.7 ...

Doctor Salvador Plasencia was accused of providing ketamine to Friends actor Matthew Perry. He died at the age of 54 in ...

Mental health is not just depression, schizophrenia, a mood disorder, anxiety; it has all of the things. We are trying to ...

Credence Behavioral Health opened its doors in Lynchburg. Now, the outpatient clinic is serving over 1,700 patients, and ...

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

On Friday, July 18, the Lynchburg Regional Business Alliance and Credence Behavioral Health officially cut the ribbon to ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a clinical-stage neuropsychiatry company, announced UK MHRA approval to initiate EMBRACE, the second pivota ...

More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia ...

Florida is stepping up its efforts to help abate veteran suicide by agreeing to spend $300,000 this year to expand statewide ...

Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced ...

Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

Market reaction to recent readouts from Compass Pathways and Beckley Psytech/atai in treatment-resistant depression speaks to ...